Children and adults have two major types of adipocytes, which represent the predominant cells in white adipose tissue, which is involved in energy storage, and brown adipose tissue (BAT), which is responsible for thermogenesis and energy expenditure. This review discusses BAT physiology and evaluates the recent discoveries regarding its development, identification, and function.
Introduction
The current obesity pandemic is a having a disproportionately large effect on the pediatric population. In the United States, the prevalence of overweight children and adolescents has tripled in the past four decades to over 16%, with even higher percentages in ethnic minorities [1] . Coupled with this is the alarming growth in obesityrelated diseases rarely seen previously in children, including type 2 diabetes, nonalcoholic fatty liver disease, and sleep apnea [2 ] . We now face the possibility in the coming century that this disease may actually lower life expectancy. The situation has become so dire that, in February 2010, President Barack Obama established a task force on childhood obesity to 'develop an interagency action plan to solve the problem of obesity among our Nation's children within a generation' [3] .
The evolving understanding of adipose tissue
Obesity develops when energy intake exceeds energy expenditure. Classically, adipose tissue has been viewed as playing a passive role as a storage depot for excess calories. This view has changed dramatically over the past two decades, as adipose tissue is now known to be an active endocrine organ, releasing free fatty acids and adipokines such as leptin, adiponectin, tumor necrosis factor-alpha, interleukin-6, and retinol-binding protein-4, all of which can act on other tissues, including the brain, liver, and muscle to regulate food intake, energy balance, insulin sensitivity, and even reproduction [4, 5] .
It is not just the size but the distribution of adipose tissue that matters. An increase in intraabdominal/visceral fat is associated with a high risk of metabolic disease, whereas excess subcutaneous fat in the thighs and hips exerts little or no risk. Recent evidence indicates that these functional differences may be inherent to the different types of adipocytes residing in the various depots [6] . In addition to white adipose tissue (WAT), mammals also have brown adipose tissue (BAT), which burns energy for thermogenesis. In the past 2-3 years, we have witnessed a revolution in our understanding of BAT from the molecular to the clinical level.
The nature of the whole-body adipose tissue depot
Our knowledge of fat, especially BAT, has been influenced significantly by studies in rodent models. There, the macroscopic view suggests a simple dichotomy, with multiple WAT depots throughout the body and one BAT depot situated between the scapulae. However, small collections of brown adipocytes have been identified intermixed with white adipocytes and between skeletal muscle bundles in some obesity-resistant strains of mice, suggesting a role for BAT in the control of body weight [7, 8] . Close histological analysis has shown that many adipose tissue depots are a mix of white and brown adipocytes wherein the balance is influenced by age, strain/genetics, environment, nutrition, and drugs [9] .
In contrast to muscle, which generates heat by reactions within its cytoplasm, BAT thermogenesis takes place in its numerous, densely-packed mitochondria containing the BAT-specific inner membrane protein uncoupling protein 1 (UCP-1). At the molecular level, norepinephrine triggers a signaling cascade that activates UCP-1, which then uncouples aerobic respiration by dissipating the intermembrane proton-motive force, creating a futile cycling of ions, thus generating heat instead of ATP [9] . In a cold-acclimatized rat, oxygen consumption by BAT, which represents less than 2% of body weight, is approximately twice the whole-body basal metabolic rate under thermoneutral conditions [10] . UCP-1 is unique to brown adipocytes and is necessary for BAT thermogenesis [11] . However, brown adipocytes can also be distinguished from white adipocytes at the molecular level by their higher levels of expression of type 2 iodothyronine deiodinase, the transcription coregulators PR domain containing 16 and peroxisome proliferator-activated receptor gamma coactivator-1alpha, and Cidea, a regulator of lipolysis [6] .
In rodents, BAT generates heat for two principal reasons: to protect against cold exposure via nonshivering thermogenesis, and to burn off excess calories and reduce adiposity [12, 13] . Thus, BAT has a central role in protecting mice from diet-induced obesity, and ablation of BAT reduces energy expenditure and increases obesity in response to high-fat diets [14] . In adult humans, the potential contribution of BAT to metabolism is debated, but it has been estimated that as little as 50 g of BAT could utilize up to 20% of basal caloric needs if maximally stimulated [15] .
Anatomical distribution of pediatric brown adipose tissue
BAT has been known for over 50 years to exist in children from two pivotal autopsy studies: one [16] reviewing over 400 necropsies on infants from 29 weeks of gestation to 4 weeks postpartum and the other of 52 humans ages 0 to over 80 years [17] . These revealed that the distribution of BAT in infants is largely similar to that of adults. The primary depots surround the cervical muscles and vasculature, particularly the carotid sheath, and extend below the clavicles into the axillae and sometimes the thorax following the great vessels, esophagus, and trachea. In the abdomen, discrete masses of BAT accompany the aorta and lie near posterior structures such as the pancreas, autonomic ganglia, kidneys, and adrenal glands. There also is an interscapular depot, thought to correspond to the major depot in rodents, which lies in a diamondshaped sheet separated from the subcutaneous WAT by a discontinuous fibrous layer [16] .
Immature brown adipocytes can be seen as early as 29 weeks' gestation. Growth during the third trimester appears to be by the expansion of cell volume from mitochondriogenesis. Postpartum, cells continue to grow and can double in size by week 5. During this period, cellular lipid content declines, particularly in premature infants, suggesting a role for BAT in newborns in thermogenesis. [16] . Human newborns have an estimated 30 g of BAT, representing 1% of body weight [18] . As children leave the first decade of life, the wide distribution of BAT declines such that the more peripherally situated areas, such as interscapular and abdominal wall depots, disappear. However, the deeper depots are maintained even into the ninth decade [17] . Histologically, BAT in the mediastinal and paraaortic depots in infants is more homogeneous tissue, intermixed with few white adipocytes, whereas brown and white adipocytes are intermixed in other sites, including the interscapular, cervical, axillary, and perirenal depots. Brown adipocytes in infants have a rich capillary and neuronal supply, suggesting that both pathways may be involved in BAT activation [16] .
Although the data support a role for BAT in children in nonshivering thermogenesis, the relative contribution of BAT in various depots in children is unclear. Many studies suggest that interscapular BAT is the major source of thermogenesis, implying similarities to rodent physiology. However, there was little direct evidence for this except for increases in skin-surface temperature overlying the interscapular region [19, 20] . A similar assumption was made in the adult, but biopsies of these warmer sites show no BAT, suggesting that this temperature gradient is due to a lower insulating fat thickness and increased blood flow, rather than BAT [21] . Indeed, this and similar studies led to the conclusion among many that there are no significant amounts of functional BAT anywhere in human adults, a conclusion that has been clearly disproven by recent PET-computed tomography (CT) studies discussed below.
Brown adipose tissue physiology in children
Given its wide and scattered distribution, measuring the contribution of BAT to energy expenditure in children is a theoretical and practical challenge that has been addressed differently over the past decades. Initially, investigators relied on histological appearance to assess the functional state of brown adipocytes with the assumption that if there were less lipid, then the tissue was less active. This approach was supported by findings in children exposed to cold [19] and rodent studies [22, 23 ] . It also appears that, as humans age, BAT becomes less functional as lipid accumulates to the point where BAT becomes indistinguishable from WAT (reviewed in [24] ). The discovery of UCP-1 in 1976 [25] followed by the development of sensitive ELISAs and radioimmunoassays to UCP-1 [26, 27] permitted a more accurate assessment of BAT content and indicated that older infants and young children had considerably more BAT than either preterm infants, stillborns, or human adults [28] . In newborns, BAT can contribute significantly to metabolism. In a study [20] of children 6-30-h old, cooling to 25-268C for 20 min led to a doubling of oxygen consumption, thought to be due to BAT.
BAT functionality is also dependent on nutritional status. In a study [19] of malnourished Jamaican children aged 4-16 months, there was an impaired response to cold exposure as measured by oxygen consumption, rectal temperature, and skin-surface temperature overlying the interscapular region compared with when they recovered. In a second part of that study, the cervical and interscapular BAT in a different set of malnourished children aged 1-24 months showed lipid depletion, suggesting that normal caloric intake is necessary to maintain proper BAT function. Also of note is that there was no shivering seen in these children, making it likely that BAT is a major form of thermogenesis until at least the second year of life [19] .
One circumstance that has led to a greater understanding of the potential contribution of BAT to thermogenesis in children has been the search for a connection between hyperactive BAT and 'cot death,' now referred to as sudden infant death syndrome (SIDS). One case report described two infants, aged 5 months, who were found with core body temperatures above 408C. At autopsy BAT from the cervical, axillary, interscapular, and perirenal depots showed normal amounts of UCP-1, cytochrome oxidase, and guanosine 5'-diphosphate (GDP)binding activity compared with the BAT in other species [29] . On the basis of an oxygen consumption of maximally stimulated murine BAT of 1.5 ml O 2 /min, and assuming 30 g of BAT in human neonates, the maximal heat output of neonatal BAT could be 250 cal/min, which is twice the normal basal metabolic rate and could raise core temperature 5-68C/h [29] . Though suggestive of a connection between malfunctioning BAT and SIDS, a larger study of 88 infants who died of SIDS showed no differences in periadrenal BAT when compared with 62 children who died of other causes. However, these authors extended previous studies by showing that BAT activity, as defined by histological appearance, increased after birth, peaked at 4-8 weeks, and then slowly declined into adolescence [30] . They also described the heterogeneous nature of periadrenal fat, which contained a range of brown and white adipocytes [30] . Unfortunately, no studies have true measures of BAT metabolic activity.
Given that children have more BAT than adults, one question is whether this difference is manifested physiologically, for example, by greater resistance to cooling, such that children could tolerate cold exposure better than adults. One measure of this might be the cold pressor test (CPT) in which a hand or forearm is placed in water at 108C. This produces slowly increasing pain of mild-to-moderate intensity, so the primary outcome measure is the duration for which the individual can maintain the limb in the cold water. The CPT has been used in many studies of pain, autonomic reactivity, and hormonal stress responses (reviewed in [31] ). Moreover, it is now known that this kind of cold exposure activates human BAT [32 ,33 ] . Studies to date have found that cold pain intensity ratings are predicted by sex [34] and distractability [35] , but there is little information comparing children with adults, integrating this response to measures of BAT activity. Other quantitative measures of cold tolerance or intolerance are lacking at present.
A connection between brown adipose tissue and obesity?
The central role BAT plays in normal metabolism suggests that mutations in certain genes, especially BAT-specific UCP-1, could have significant effects on whole-body energy homeostasis. Though sequence variations have been found in the human UCP-1 gene, to date no profound effect has been identified. In a study [36] of French Canadians, a rare allele of a nucleotide polymorphism was more frequent among people who gained more weight over a 12-year interval. A more extensive study of the human UCP-1-coding region uncovered five substitutions that altered the UCP-1 protein's primary amino acid sequence. The frequencies of the mutations were compared among Danish men but were not associated with obesity [37] . A À3826 A ! G nucleotide variant in the UCP-1 promoter has been associated with a reduction in the thermic effect of food in spite of increased sympathetic output in a cohort of Japanese boys aged 8-11 years [38] . Other physiological studies have suggested that genetic differences in thermogenesis may play a role in predisposition toward obesity. For example, children of obese parents have, on average, a 20% lower energy requirement compared with those from normal-weight parents [39] . These and similar data suggest that reduced diet-induced thermogenesis from BAT, through either mutation or reduced function, may contribute to why obesity-prone children are found to have lower energy requirements and be in positiveenergy balance on a 'normal' food intake [40] . These findings also imply that, at least in children, BAT may play a role in diet-induced thermogenesis, and impaired UCP-1 function may contribute to pediatric obesity.
Recent advances in brown adipose tissue biology
The past several years have seen tremendous progress in understanding the origin of brown adipocytes and the regulation of their development. Brown adipocytes are derived from multipotent mesenchymal stem cells [6] , but different anatomical locations may have distinct lineages. For example, in the mouse, interscapular and perirenal BAT develop from myf5-expressing myogenic precursors [41, 42] , whereas systemic brown fat cells seen within white fat tissue and interspersed within muscle appear to derive from myf5-negative cells and have different features, including greater sensitivity to b3-adrenergic stimulation and cold exposure [7, 8, [42] [43] [44] . A current scheme for brown adipogenesis is shown in Fig. 1. For years, the best known inducer of brown adipogenesis and function has been norepinephrine [45] , but recent studies have identified additional specific secreted signaling molecules, including nodal, wingless, and members of the fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) families [6] . The BMPs in particular are of interest because they are secreted proteins in the transforming growth factor-beta superfamily that can promote both brown and white adipogenesis [46] . BMP-7 has been shown to be a powerful inducer of brown adipogenesis, whereas BMP-2 and BMP-4 are strong inducers of WAT. Adenoviral-mediated expression of BMP-7 in liver of mice has been shown to increase BAT mass and energy expenditure and to reduce weight gain [47] .
Rediscovery of brown fat in adult humans
Though BAT was known to exist and have a physiological role in children, BAT was thought to be nonexistent The development of a fully functional brown adipocyte can be divided into three phases: the multipotent mesenchymal stem cell, the brown preadipocytes, and the mature brown adipocytes. Shown for each phase are key hormonal regulators (left) and transcriptional regulators (italics, center). BMP7, bone morphogenetic protein 7; FGFs, fibroblast growth factors; IGF-1, insulin-like growth factor 1; PGC-1a, PPARgamma coactivator-1alpha; PRDM, PR domain containing 16. and nonfunctional in adults because attempts to find functional BAT during life [49] or utilize its thermogenesis for weight loss [50, 51] had been largely unsuccessful [52, 53] . Beginning in 2002, reports in the radiological literature using PET-CT suggested this might not be true. PET uses radiotracers such as 18 F-fluorodeoxyglucose ( 18 F-FDG) to measure the metabolic activity of tissues in living organisms. CT provides high-resolution anatomical detail. Fusion of the PET and CT images provides both functional and structural information in a single image (Fig. 2 [48] ). In the course of using PET-CT to detect and stage tumors [54] , radiologists noted FDG-avid adipose tissue in the same sites seen 30 years previously [17, 55, 56] . This tissue was often called 'BAT' in the radiological literature, but endocrinologists doubted these findings, in part, because of the lack of immunohistochemical evidence.
Then, in 2009, several studies fundamentally altered our understanding of adult human BAT, with implications for pediatric BAT as well. Five independent groups [32 ,33 ,57 -59 ] used 18 F-FDG PET-CT to identify and characterize the presence and relevance of BAT in adult humans. All showed major depots of metabolically active fat in the cervical-supraclavicular region that had UCP-1 and histological characteristics of BAT, and one group [32 ] also demonstrated the gene and protein expression of UCP-1. In our retrospective study of almost 2000 adults undergoing PET-CT, we found an inverse correlation between BAT activity and average outdoor temperature, beta-blocker medication use and BMI, indicating that adult human BAT responds to stimulation by the sympathetic nervous system and likely participates in both cold-induced and diet-induced thermogenesis. The location of the most highly active BAT in adult humans was in the cervical-supraclavicular depot [57 ] .
The wide use of FDG-PET also permits an assessment of BAT activity in children. In a study [60] of children aged 1.2-22.6 years, metabolically active BAT was found in cervical and supraclavicular depots as well as paraspinally, but not interscapularly. Thus, BAT in children is in essentially the same depots identified histologically decades before [16, 17] . In addition, studies [48, [60] [61] [62] 63 ] have shown that interscapular BAT in children, if it exists, does not take up much FDG and is not likely metabolically active, which stands in direct contrast to rodent studies [22, 64, 65] showing high uptake even under basal conditions.
BAT in children and adults differs significantly in terms of overall activity when measured by PET. In children, the detection rate in nonstimulated individuals is much higher, up to 31% [63 ] , compared with 5% in adults [57 ] , and the frequency is equal in girls and boys [60] instead of displaying the marked female predominance seen in adults [57 ] . BAT activity is also modifiable, as pretreatment of children with opiates such as fentanyl or anxiolytics such as diazepam reduces FDG uptake [60] . Simply increasing the ambient room temperature from 21 to 248C also reduces FDG uptake by BAT in children [63 ] . The physiological implications of these findings are now an exciting area for discovery.
Conclusion
The obesity pandemic in children presents a unique set of challenges. Harnessing the thermogenic, fat-burning power of BAT is clearly an attractive new therapeutic target. As treatments with growth factors, such as BMPs and FGFs, or adrenergic agents are not likely to be employed because of their pleiotropic effects, further research will be required to find safe methods, such as mild cold exposure, to increase BAT function for treatment or prevention of obesity. For now, combating childhood obesity will rely on reducing caloric intake and increasing energy expenditure through exercise. Kidney Diseases (NIDDK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National NIDDK or the NIH. Dr Cypess reports being the sole inventor on a pending patent application to use infrared thermography to monitor BAT. Dr Kahn reports being an advisory board member for Sirtris, Plexxicon, Fiveprime, and Dicerna; owns equity in GSK, Plexxicon, and Fiveprime; receives lecture fees from Wyeth, Novartis, and Novo-Nordisk; and has a pending patent in the area of stimulating brown fat growth with BMPs.
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